Common use of Authorization to Use and Disclose Health Information Clause in Contracts

Authorization to Use and Disclose Health Information. Principal Investigator shall provide an appropriate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. Principal Investigator will only use the authorization that is provided by Sponsor. 10.1.

Authorization to Use and Disclose Health Information. Institution agrees that Principal Investigator shall provide an appropriate privacy notice to each Trial Study Subject and obtain a written privacy authorization from each Trial Study Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor Sponsor, CRO and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. Principal Investigator will only use the authorization that is provided by Sponsor. If 10.1.

Authorization to Use and Disclose Health Information. Principal Investigator shall provide an appropriate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. Institution and Principal Investigator will only use the authorization that is provided approved by Sponsor. 10.1.

Authorization to Use and Disclose Health Information. Principal Investigator shall provide an appropriate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. Principal Investigator will only use the authorization that is provided approved by SponsorSponsorand acknowledged by EC. 10.1.